Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DW24 | ISIN: SE0008091664 | Ticker-Symbol: 5LU
Frankfurt
06.02.26 | 08:09
0,007 Euro
-14,63 % -0,001
1-Jahres-Chart
SIMRIS GROUP AB Chart 1 Jahr
5-Tage-Chart
SIMRIS GROUP AB 5-Tage-Chart

Aktuelle News zur SIMRIS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SIMRIS GROUP Aktie jetzt für 0€ handeln
19.01.Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting163Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting. Election...
► Artikel lesen
12.11.25Simris Group AB receives observation status140Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation. The rules of Nasdaq...
► Artikel lesen
12.11.25Simris Group AB: Simris Group Interim Report January-september 2025167QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM...
► Artikel lesen
10.11.25Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO195The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately. Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and...
► Artikel lesen
05.11.25Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan180Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development...
► Artikel lesen
06.10.25Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads236Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and...
► Artikel lesen
12.09.25Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs)874Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for...
► Artikel lesen
13.08.25Simris Group AB: Simris Group Interim Report January-june 2025214QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD...
► Artikel lesen
14.07.25Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review209Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug...
► Artikel lesen
28.05.25Simris Group AB: Bulletin from Simris Group AB's annual general meeting324Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting. Income...
► Artikel lesen
14.05.25Simris Group AB: Simris Group Interim Report January-march 2025397QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7...
► Artikel lesen
26.02.25Simris Group AB: Simris Group Year-end Report January-december 2024252QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1